Association of body mass index with all-cause mortality in patients with diabetes: A systemic review and meta-Analysis

Cardiovascular Diagnosis and Therapy

Volumn 6, Issue 2, 2016, Pages 109-119

  Chang, Hsiao Wen ^a,b   Li, Yi Hwei ^c   Hsieh, Chang Hsun ^a   Liu, Pang Yen ^a   Lin, Gen Min ^a,c,d  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b KAOHSIUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

All cause mortality; Body mass index (BMI); Obesity paradox; Type 2 diabetes

Indexed keywords

ARTICLE; BODY MASS; COHORT ANALYSIS; DISEASE DURATION; FOLLOW UP; HUMAN; MORBID OBESITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; UNDERWEIGHT;

EID: 84994715766     PISSN: 22233652     EISSN: 22233660     Source Type: Journal    
DOI: 10.21037/cdt.2015.12.06     Document Type: Article

References (31)

1. Sturm R. Increases in clinically severe obesity in the United States, 1986-2000. Arch Intern Med 2003;163:2146-8.
2. Lin GM, Li YH, Lin CL, et al. Relation of body mass index to mortality among Asian patients with obstructive coronary artery disease during a 10-year follow-up: A report from the ET-CHD registry. Int J Cardiol 2013;168:616-20.
3. Wohlfahrt P, Lopez-Jimenez F, Krajcoviechova A, et al. The obesity paradox and survivors of ischemic stroke. J Stroke Cerebrovasc Dis 2015;24:1443-50.
4. Lavie CJ, Alpert MA, Arena R, et al. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 2013;1:93-102.
5. Park J, Ahmadi SF, Streja E, et al. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis 2014;56:415-25.
6. Tseng CH. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus. Atherosclerosis 2013;226:186-92.
7. Tobias DK, Pan A, Jackson CL, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med 2014;370:233-44.
8. Ross C, Langer RD, Barrett-Connor E. Given diabetes, is fat better than thin? Diabetes Care 1997;20:650-2.
9. Chaturvedi N, Fuller JH. Mortality risk by body weight and weight change in people with NIDDM. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care 1995;18:766-74.
10. Zhao W, Katzmarzyk PT, Horswell R, et al. Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus. Circulation 2014;130:2143-51.
11. Lavie CJ, McAuley PA, Church TS, et al. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 2014;63:1345-54.
12. De Schutter A, Lavie CJ, Patel DA, et al. Obesity paradox and the heart: which indicator of obesity best describes this complex relationship? Curr Opin Clin Nutr Metab Care 2013;16:517-24.
13. George AM, Jacob AG, Fogelfeld L. Lean diabetes mellitus: An emerging entity in the era of obesity. World J Diabetes 2015;6:613-20.
14. GA Wells, B Shea, D O'Connell, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses. Available online: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp
15. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-Analyses. BMJ 2003;327:557-60.
16. Costanzo P, Cleland JG, Pellicori P, et al. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: A cohort study. Ann Intern Med 2015;162:610-8.
17. Jackson CL, Yeh HC, Szklo M, et al. Body-Mass Index and All-Cause Mortality in US Adults With and Without Diabetes. J Gen Intern Med 2014;29:25-33.
18. Lajous M, Bijon A, Fagherazzi G, et al. Body mass index, diabetes, and mortality in French women: explaining away a "paradox". Epidemiology 2014;25:10-4.
19. Logue J, Walker JJ, Leese G, et al. Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care 2013;36:887-93.
20. Carnethon MR, De Chavez PJ, Biggs ML, et al. Association of weight status with mortality in adults with incident diabetes. JAMA 2012;308:581-90.
21. McEwen LN, Karter AJ, Waitzfelder BE, et al. Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD). Diabetes Care 2012;35:1301-9.
22. Lyerly GW, Sui X, Lavie CJ, et al. The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus. Mayo Clin Proc 2009;84:780-6.
23. Khalangot M, Tronko M, Kravchenko V, et al. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: A large prospective study in Ukraine. Heart 2009;95:454-60.
24. Mulnier HE, Seaman HE, Raleigh VS, et al. Mortality in people with type 2 diabetes in the UK. Diabet Med 2006;23:516-21.
25. Zoppini G, Verlato G, Leuzinger C, et al. Body mass index and the risk of mortality in type II diabetic patients from Verona. Int J Obes Relat Metab Disord 2003;27:281-5.
26. Ford ES, DeStefano F. Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Am J Epidemiol 1991;133:1220-30.
27. Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: A systematic review. Ann Intern Med 2004;140:211-9.
28. Willi C, Bodenmann P, Ghali WA, et al. Active smoking and the risk of type 2 diabetes: A systematic review and meta-Analysis. JAMA 2007;298:2654-64.
29. Mehta T, Fontaine KR, Keith SW, et al. Obesity and mortality: Are the risks declining? Evidence from multiple prospective studies in the United States. Obes Rev 2014;15:619-29.
30. Oreopoulos A, Kalantar-Zadeh K, Sharma AM, et al. The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med 2009;25:643-59, viii.
31. Cherin P, Voronska E, Fraoucene N, et al. Prevalence of sarcopenia among healthy ambulatory subjects: The sarcopenia begins from 45 years. Aging Clin Exp Res 2014;26:137-46.